Trials / Unknown
UnknownNCT02682394
Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas
Prognostic Importance of Quantitative Magnetic Resonance Imaging for Evaluation of Pancreatic Steatosis in Patients With Pancreatic Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Soroka University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prognostic Importance of Quantitative Magnetic Resonance Imaging for Evaluation of Pancreatic Steatosis in Patients with Pancreatic Cancer
Detailed description
1. Finding patients with pancreatic cancer (in all stages), before any treatment. 2. Non invasively quantify fatty infiltration of pancreas using, MRI DIXON Scan in pancreatic cancer patient relatively to liver. 3. Measuring cell-free blood DNA in those patients for evaluating the aggressiveness of the disease. 4. Quantify the prognostic significance of pancreatic steatosis in comparison with clinical and pathological prognostic indexes used today.
Conditions
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2017-09-01
- Completion
- 2017-10-01
- First posted
- 2016-02-15
- Last updated
- 2016-02-15
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02682394. Inclusion in this directory is not an endorsement.